| Mount Carmel Rehabilitation And Nursing Center | |
| 235 Myrtle Street, Manchester, New Hampshire 03104 | |
| (603) 627-3811 | |
| Name | Mount Carmel Rehabilitation And Nursing Center |
|---|---|
| Location | 235 Myrtle Street, Manchester, New Hampshire |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 122 |
| Occupancy Rate | 71.8% |
| Medicare ID (CCN) | 305067 |
| Legal Business Name | Mount Carmel Rehabilitation & Nursing Center |
| Ownership Type | Non Profit - Church Related |
| NPI Number | 1265678221 |
| Organization Name | GENESIS HEALTHCARE AND REHAB |
| Address | 235 Myrtle St, Manchester, NH 03104 |
| Phone Number | 603-627-3811 |
News Archive
Patients with a first-time depression diagnosis have an increased risk of the disease worsening and requiring hospitalization, if they have previously been treated for a physical disease at a hospital.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
Parents who smoke cigarettes around their kids in cars and homes beware - second-hand smoke may trigger symptoms of nicotine dependence in children. The findings are published in the September edition of the journal Addictive Behaviors in a joint study from nine Canadian institutions.
Writing in the Center for Strategic & International Studies' "Smart Global Health" blog, J. Stephen Morrison, CSIS senior vice president and director of the center's Global Health Policy Center, discusses the history of the Global Health Initiative and the recent creation of the State Department's Office of Global Health Diplomacy.
› Verified 9 days ago
| NPI Number | 1376530246 |
| Organization Name | MOUNT CARMEL REHABILITATION & NURSING CENTER |
| Doing Business As | MOUNT CARMEL REHAB CENTER |
| Address | 235 Myrtle St, Manchester, NH 03104 |
| Phone Number | 603-627-3811 |
News Archive
Patients with a first-time depression diagnosis have an increased risk of the disease worsening and requiring hospitalization, if they have previously been treated for a physical disease at a hospital.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
Parents who smoke cigarettes around their kids in cars and homes beware - second-hand smoke may trigger symptoms of nicotine dependence in children. The findings are published in the September edition of the journal Addictive Behaviors in a joint study from nine Canadian institutions.
Writing in the Center for Strategic & International Studies' "Smart Global Health" blog, J. Stephen Morrison, CSIS senior vice president and director of the center's Global Health Policy Center, discusses the history of the Global Health Initiative and the recent creation of the State Department's Office of Global Health Diplomacy.
› Verified 9 days ago
| NPI Number | 1558594374 |
| Address | 235 Myrtle Street, Manchester, NH 03104 |
| Phone Number | 603-627-3811 |
News Archive
Patients with a first-time depression diagnosis have an increased risk of the disease worsening and requiring hospitalization, if they have previously been treated for a physical disease at a hospital.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
Parents who smoke cigarettes around their kids in cars and homes beware - second-hand smoke may trigger symptoms of nicotine dependence in children. The findings are published in the September edition of the journal Addictive Behaviors in a joint study from nine Canadian institutions.
Writing in the Center for Strategic & International Studies' "Smart Global Health" blog, J. Stephen Morrison, CSIS senior vice president and director of the center's Global Health Policy Center, discusses the history of the Global Health Initiative and the recent creation of the State Department's Office of Global Health Diplomacy.
› Verified 9 days ago
| NPI Number | 1932337110 |
| Organization Name | GENESIS ELDERCARE REHAB SVCS |
| Address | 235 Myrtle St, Manchester, NH 03104 |
| Phone Number | 603-627-3811 |
News Archive
Patients with a first-time depression diagnosis have an increased risk of the disease worsening and requiring hospitalization, if they have previously been treated for a physical disease at a hospital.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
Parents who smoke cigarettes around their kids in cars and homes beware - second-hand smoke may trigger symptoms of nicotine dependence in children. The findings are published in the September edition of the journal Addictive Behaviors in a joint study from nine Canadian institutions.
Writing in the Center for Strategic & International Studies' "Smart Global Health" blog, J. Stephen Morrison, CSIS senior vice president and director of the center's Global Health Policy Center, discusses the history of the Global Health Initiative and the recent creation of the State Department's Office of Global Health Diplomacy.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Patients with a first-time depression diagnosis have an increased risk of the disease worsening and requiring hospitalization, if they have previously been treated for a physical disease at a hospital.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
Parents who smoke cigarettes around their kids in cars and homes beware - second-hand smoke may trigger symptoms of nicotine dependence in children. The findings are published in the September edition of the journal Addictive Behaviors in a joint study from nine Canadian institutions.
Writing in the Center for Strategic & International Studies' "Smart Global Health" blog, J. Stephen Morrison, CSIS senior vice president and director of the center's Global Health Policy Center, discusses the history of the Global Health Initiative and the recent creation of the State Department's Office of Global Health Diplomacy.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.73 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.62 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 61.34 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.15 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.57 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.29 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.18 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.73 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 0.57 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 63.1 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.56 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.1 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.31 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.88 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 81.61 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 82.82 | 82.93 |
News Archive
Patients with a first-time depression diagnosis have an increased risk of the disease worsening and requiring hospitalization, if they have previously been treated for a physical disease at a hospital.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
Parents who smoke cigarettes around their kids in cars and homes beware - second-hand smoke may trigger symptoms of nicotine dependence in children. The findings are published in the September edition of the journal Addictive Behaviors in a joint study from nine Canadian institutions.
Writing in the Center for Strategic & International Studies' "Smart Global Health" blog, J. Stephen Morrison, CSIS senior vice president and director of the center's Global Health Policy Center, discusses the history of the Global Health Initiative and the recent creation of the State Department's Office of Global Health Diplomacy.
› Verified 9 days ago
Hanover Hill Health Care Center Location: 700 Hanover Street, Manchester, New Hampshire 03104 Phone: (603) 627-3826 | |
Maple Leaf Health Care Center Location: 198 Pearl Street, Manchester, New Hampshire 03104 Phone: (603) 669-1660 | |
Hackett Hill Healthcare Center Location: 191 Hackett Hill Road, Manchester, New Hampshire 03102 Phone: (603) 668-8161 | |
Courville At Manchester Location: 44 West Webster Street, Manchester, New Hampshire 03104 Phone: (603) 647-5900 | |
Mount Carmel Rehabilitation And Nursing Center Location: 235 Myrtle Street, Manchester, New Hampshire 03104 Phone: (603) 627-3811 | |
Saint Teresa Rehabilitation & Nursing Center Location: 519 Bridge Street, Manchester, New Hampshire 03104 Phone: (603) 668-2373 |